Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613
Guardado Rivas, Moises O, Stuart, Shawn D, Thach, Daniel, Dahan, Michael, Shorr, Robert, Zachar, Zuzana, Bingham, Paul M
Published in PloS one (08.06.2022)
Published in PloS one (08.06.2022)
Get full text
Journal Article
Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613
Moises O Guardado Rivas, Shawn D Stuart, Daniel Thach, Michael Dahan, Robert Shorr, Zuzana Zachar, Paul M Bingham
Published in PloS one (01.01.2022)
Published in PloS one (01.01.2022)
Get full text
Journal Article